Differentiation induction subtraction hybridization (DISH): A strategy for cloning genes displaying differential expression during growth arrest and terminal differentiation

Gene

Volumn 236, Issue 1, 1999, Pages 125-131

  Huang, Fei ^a,b   Adelman, Jennifer ^a   Jiang, Hongping ^a,b   Goldstein, Neil I ^a   Fisher, Paul B ^b  

^a GenQuest Incorporated   (United States)

^b Departments of Neurosurgery Anatomical Pathology   (United States)

Author keywords

Differentially expressed cDNAs; Melanoma terminal differentiation; Reverse northern

Indexed keywords

BETA INTERFERON; MEZEREIN;

ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DIFFERENTIATION INDUCTION SUBTRACTION HYBRIDIZATION; DNA LIBRARY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRIDIZATION; IN VITRO STUDY; MELANOMA CELL; MOLECULAR CLONING; PRIORITY JOURNAL; TECHNIQUE;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; CLONING, MOLECULAR; DITERPENES; DNA, COMPLEMENTARY; GENE LIBRARY; HUMANS; INTERFERON-BETA; MELANOMA; NUCLEIC ACID HYBRIDIZATION; TERPENES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032769247     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00244-9     Document Type: Article

References (29)

1. Alama A., Barbieri F., Cagnoli M., Schettini G. Antisense oligonucleotides as therapeutic agents. Pharmacol. Res. 36:1997;171-178. Review.
2. Armstrong B.K., Kricker A. Cutaneous melanoma. Cancer Survey. 19/20:1994;219-240.
3. Augustine K. Antisense approaches for investigating mechanisms of abnormal development. Mutation Res. 396:1997;175-193. Review.
4. Clark W. Tumor progression and the nature of cancer. Br. J. Cancer. 64:1991;631-644.
5. Earnshaw D.J., Gait M.J. Progress toward the structure and therapeutic use of the hairpin ribozyme. Antisense Nucl. Acid Drug Devel. 7:1998;403-411. Review.
6. Fisher P.B., Prignoli D.R., Hermo H. Jr., Weinstein I.B., Pestka S. Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J. Interferon Res. 5:1985;11-22.
7. Giovanella B.C., Stehlin J.S., Santamaria C., Yim S.O., Morgan A.C., Williams L.J., Leibovitz A., Fialkow P.Y., Mumford D.M. Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes. J. Natl. Cancer Inst. 56:1976;1131-1142.
8. Guarini L., Temponi M., Edwalds G.M., Vita J.R., Fisher P.B., Ferrone S. In vitro differentiation and antigenic changes in human melanoma cell lines. Cancer Immunol. Immunother. 30:1989;363-370.
9. Guarini L., Graham G.M., Jiang H., Ferrone S., Zucker S., Fisher P.B. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents. Pigment Cell Res. Suppl. 2:1992;123-131.
10. Herlyn M. Human melanoma: development and progression. Cancer Metastasis Rev. 9:1990;101-112.
11. Hermann T., Westhof E. RNA as a drug target: chemical modeling and evolutionary tools. Curr. Opin. Biotech. 9:1998;66-73. Review.
12. Huang F., Adelman J., Jiang H., Goldstein N.I., Fisher P.B. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells. Oncogene. 18:1999;3546-3552.
13. Jiang H., Fisher P.B. Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol. Cell. Different. 1:1993;285-299.
14. Jiang H., Su Z.-z., Boyd J., Fisher P.B. Gene expression changes associated with reversible growth suppression and the induction of terminal differentiation in human melanoma cells. Mol. Cell. Different. 1:1993;41-66.
15. Jiang H., Lin J., Fisher P.B. A molecular definition of terminal differentiation in human melanoma cells. Mol. Cell. Different. 2:1994;221-239.
16. Jiang H., Lin J.J., Su Z.-z., Goldstein N.I., Fisher P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 11:1995;2477-2486.
17. Jiang H., Lin J., Su Z.-z., Kerbel R.S., Herlyn M., Weissman R.B., Welch D., Fisher P.B. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene. 10:1995;1855-1864.
18. Jiang H., Lin J., Young S.-m., Goldstein N.I., Waxman S., Davila V., Chellappan S.P., Fisher P.B. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Oncogene. 11:1995;1179-1189.
19. Jiang H., Su Z.-z., Lin J.J., Goldstein N.I., Young C.S.H., Fisher P.B. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. USA. 93:1996;9160-9165.
20. Jiang H., Lin J.J., Tao J., Fisher P.B. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-β Oncogene. 14:1997;473-480.
21. Kang D.-c., Motwani M., Fisher P.B. Role of the transcription factor AP1 in melanoma differentiation. Int. J. Oncology. 13:1998;1117-1126. Review.
22. Lin J.J., Jiang H., Fisher P.B. Characterization of a novel melanoma differentiation associated gene, mda-9, that is down-regulated during terminal cell differentiation. Mol. Cell. Different. 4:1996;317-333.
23. Lin J.J., Jiang H., Fisher P.B. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene. 207:1998;105-110.
24. Lu C., Kerbel R.S. Cytokines, growth factors and the loss of negative controls in the progression of human cutaneous malignant melanoma. Curr. Opin. Oncol. 6:1994;212-220.
25. Roberts T., Vrana J.A., Grant S., Fisher P.B. Differentiation therapy of cancer: basic science and clinical studies. Pharmacol. Therapeut. 1999;. in press.
26. Shalon D., Smith S.J., Brown P.O. Genome Res. 6:1996;639-645.
27. Su Z.-z., Goldstein N.I., Fisher P.B. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc. Natl. Acad. Sci. USA. 95:1998;1764-1769.
28. Su Z.-z., Madireddi M.T., Lin J.J., Young C.S.H., Kitada S., Reed J.C., Goldstein N.I., Fisher P.B. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. USA. 95:1998;14400-14405.
29. Waxman S. Differentiation Therapy. 1995;Serono Symposium Publications, Rome, Italy.